Genesco Inc (GCO)
Official siteCONSUMER CYCLICAL • APPAREL RETAIL • NYSE
Market Cap: $375.89M
Last updated: Nov 17, 2026 at 4:10 PM ET
Genesco Inc (GCO) Stock Chart
Genesco (GCO) has a latest price of $33.95 on Nov 17, 2026, 22.1% below its 52-week high of $43.60. Its price rose 6.7% over the past 12 months. The month-end price fell 30.0% over the 10 years through Oct 2026, a compound annual decline of 3.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $64.33 in Jan 2022 and its lowest $13.34 in Mar 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GCO with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GCO.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 3.1%, and over 6 months it rose 4.6%. The month-end price rose 37.4% over the 3 years through Oct 2026, a compound annual rate of 11.2%.
| Period | Change |
|---|---|
| 1 month | -6.9% |
| 3 months | -3.1% |
| 6 months | +4.6% |
| 12 months | +6.7% |
| 12 months, with dividends | +6.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +37.4% | +11.2% |
| 5 years | -37.9% | -9.1% |
| 10 years | -30.0% | -3.5% |
Price by Year
Its best calendar year was 2021, when the price rose 113.3%, and its weakest was 2017, when it fell 47.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $37.65 | +52.0% |
| 2025 | $24.77 | -42.1% |
| 2024 | $42.75 | +21.4% |
| 2023 | $35.21 | -23.5% |
| 2022 | $46.02 | -28.3% |
| 2021 | $64.17 | +113.3% |
| 2020 | $30.09 | -37.2% |
| 2019 | $47.92 | +8.2% |
| 2018 | $44.30 | +36.3% |
| 2017 | $32.50 | -47.7% |
Trading Range
The price is 5.0% below its 50-day average of $35.75 and 0.5% above its 200-day average of $33.77.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $33.95 | |
| 52-week high | $43.60 | -22.1% |
| 52-week low | $21.93 | +54.8% |
| 50-day average | $35.75 | -5.0% |
| 200-day average | $33.77 | +0.5% |
Price Risk
Over 3 years, its largest fall from a peak was 60.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.30 |
| Largest fall, 1 year | -38.8% |
| Largest fall, 3 years | -60.9% |
Valuation
Genesco traded at 28.8x earnings at the end of 2025, against a 5-year median of 22.2x and a 10-year median of 13.9x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GCO
What is GCO's 1-year price change?
Genesco's price rose 6.7% over the past 12 months. With dividends included, the 12-month total return was 6.7%.
What is GCO's 5-year price change?
Genesco's month-end price fell 37.9% over the 5 years through Oct 2026, a compound annual decline of 9.1%. These figures leave out dividends.
What is GCO's 52-week high and low?
Genesco's 52-week high is $43.60 and its 52-week low is $21.93. Its latest price of $33.95 on Nov 17, 2026 is 22.1% below the high.
What is GCO's beta?
Genesco's 1-year beta against the S&P 500 is 1.30, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 38.8%.
Is the GCO chart free?
Yes. Advanced Charting for GCO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GCO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors